Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0V8MX
|
||||
Former ID |
DNC007405
|
||||
Drug Name |
3,4,5-trimethoxy-N-(thiazol-2-yl)benzamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528805] | ||
Structure |
Download2D MOL |
||||
Formula |
C13H14N2O4S
|
||||
Canonical SMILES |
COC1=CC(=CC(=C1OC)OC)C(=O)NC2=NC=CS2
|
||||
InChI |
1S/C13H14N2O4S/c1-17-9-6-8(7-10(18-2)11(9)19-3)12(16)15-13-14-4-5-20-13/h4-7H,1-3H3,(H,14,15,16)
|
||||
InChIKey |
XSAYHNGEJLPKEX-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | mRNA of human 5-lipoxygenase | Target Info | Inhibitor | [528805] | |
NetPath Pathway | IL4 Signaling Pathway | ||||
PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.